Bär & Karrer Advises EQT and Kuoni Group on the Combination of Kuoni’s GTA Business with Hotelbeds
Kuoni Travel Holding Ltd, owned by EQT VII, a fund of the private equity group EQT, and the Kuoni and Hugentobler Foundation, has entered into a binding agreement on the sale of its GTD business division (GTA) to Hotelbeds Group, owned by a consortium led by Cinven und Canada Pension Plan Investment Board (CPPIB). The …
Bär & Karrer Advises Hellman & Friedman and GIC on the Acquisition of Allfunds
On 7 March 2017 Hellman & Friedman and GIC acquired Allfunds Bank, S.A. from Intesa Sanpaolo Group, Santander Group, General Atlantic and Warburg Pincus. Allfunds Bank is a leading financial technology business. The transaction is valued at EUR 1.8 billion and is subject to customary closing conditions. Bär & Karrer acted as Swiss legal advisor …
Continue reading “Bär & Karrer Advises Hellman & Friedman and GIC on the Acquisition of Allfunds”
Bär & Karrer Advises an Affiliate of Warburg Pincus on the Acquisition of a Stake in Avaloq
Warburg Pincus, a leading global private equity firm, has entered into an agreement to acquire approximately 35% shareholding in the Avaloq Group AG. Avaloq is an internationally leading FinTech company based in Switzerland. With its integrated business process outsourcing services, Avaloq is the only independent provider for the financial industry that does both, developing and …
Bär & Karrer Advises Mitsui on the Acquisition of Chemtrade Aglobis
On 28 February 2017, Mitsui & Co., Ltd. (Mitsui) and Chemtrade Logistics Inc. (Chemtrade) announced an agreement under which Mitsui will acquire the entire stake in Chemtrade Aglobis AG (Aglobis), subsidiary entirely owned by Chemtrade. Aglobis is a leading distributor of sulphur and sulphuric acid in Europe. The transaction is subject to relevant regulatory approvals.
Bär & Karrer Advises Lonza on the Entering into a Strategic Partnership with Sanofi to Establish a
Today, Lonza and Sanofi announced that they have entered into a strategic partnership to build and operate a large-scale mammalian cell culture facility for monoclonal antibody production in Visp, Switzerland. The large-scale facility will be established through a joint venture with an initial investment of around CHF 290 million shared equally between Lonza and Sanofi. …
Bär & Karrer on top of the Profile League Table by Mergermarket
Earlier this month Mergermarket published its review on the 2016's most prolific individual DACH legal advisors. We are pleased to be ranked with Christoph Neeracher and Luca Jagmetti on the top of the table on rank one and two. Both are associated for 2016 with 11 completed deals and a total value of EUR 3 …
Continue reading “Bär & Karrer on top of the Profile League Table by Mergermarket”
Bär & Karrer Advises Valora on the Acquisition of Pretzel Baron
Bär & Karrer Advises Valora on the Acquisition of Pretzel Baron
Bär & Karrer Advises Priora on Acquisition of Large Minority Stake in Galenica
Bär & Karrer Advises Priora on Acquisition of Large Minority Stake in Galenica
Bär & Karrer Advises Sanofi on Exchange Transaction with Boehringer Ingelheim
Bär & Karrer Advises Sanofi on Exchange Transaction with Boehringer Ingelheim
Bär & Karrer Advises Pax Anlage on the Public Takeover Offer of Baloise
Bär & Karrer Advises Pax Anlage on the Public Takeover Offer of Baloise